Showing results (161-170 of 179) with videos related to
Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancerA G Zeimet, M Widschwendter, C Knabbe, et al.British Journal of Cancer|January 15, 1999
Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitroM Widschwendter, A Widschwendter, T Welte, et al.Journal of the National Cancer Institute|May 18, 2000
Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancerM Widschwendter, J Berger, M Hermann, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2015
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upN Colombo, C Creutzberg, F Amant, et al.British Journal of Cancer|July 28, 2012
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patientsU Wagner, C Marth, R Largillier, et al.Oncogene|April 26, 2011
Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancerD Reimer, M Hubalek, H Kiefel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2016
Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO)B M Volgger, G H Windbichler, A G Zeimet, et al.Oncogene|January 27, 2010
Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancerG Hofstetter, A Berger, H Fiegl, et al.British Journal of Cancer|October 20, 2011
Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancerG Hofstetter, A Berger, E Schuster, et al.Geburtshilfe Und Frauenheilkunde|October 7, 2014
Axillary Dissection in the Case of Positive Sentinel Lymph Nodes: Results of the Innsbruck Consensus ConferenceM Hubalek, R Bartsch, M Gnant, et al.Pageof 18